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Introduction
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Integrative Processes

Human biospecimens (tissues and fluids) are an essential foundation for effective translational and
genomics-based cancer research and have proven critical for the development of personalized
cancer medicine. The demand for more high quality and clinically annotated biospecimens and the
challenge of finding them to conduct clinical research or validation studies have grown rapidly,
primarily due to an unprecedented level of genomic, post-genomic and personalized medicine
research. The increased complexity of biospecimen requests in terms of linked exhaustive clinical
variables, biospecimen types, and multidimensional longitudinal clinical follow-up data has created
new challenges but also opportunities for adapting existing collection and annotation strategies to
supply the biospecimen needs of the future.
In response to this critical need, the Miami Cancer Institute (MCI) designed and launched a
centralized Biorepository Program, to facilitate the procurement of disease-based and normal
biospecimens by providing resources and services to expedite discoveries and its translation to more
effective diagnostics and therapeutics.
Cultivating an internal collaborative infrastructure is critical for the success of new initiatives that
require multi-departmental and multidisciplinary services. It requires a logistically cohesive and
dynamic design to continuously enroll participants, collect fit-for-purpose biospecimens, and annotate
them with clinical information, and a strong operations and regulatory oversight. Six pivotal
Departments were identified to the collaborative effort: Scheduling, Surgery, Infusion Services,
Laboratory, Pathology and the Oncology Data Mart team.

The Development of the BRF Dashboard:
An Illustrative Performance Tool

Figure 6. The 2018 BRF dashboard displays the gradual growth in enrollment and biospecimen collection that
resulted from the pivotal Departments support.

Building the Collaborative Infrastructure:
The Six Pivotal Departments
Surgery
• Increased participant enrollment
• Expedited tissue procurement
• Surgeon Involvement

•
•
•
•

Clinic
Increased participant enrollment
Medical Assistant support
Clinic Operations support
Physician involvement

Infusion
• Increased participant enrollment
• Accessible, specific biofluid
• Collection for longitudinal studies

•
•
•
•

Pathology
Expedited tissue grossing
Dedicated area for tissue
processing
Tissue Quality Control
Archived tissue accessibility

Laboratory
• Continuous peripheral blood draw
at time of routine blood
collection

MCI Data Mart
• Real-time cohort identification
• Biospecimen associated clinical
data
• Alert development for
longitudinal studies

Figure 1. Collaborative Operational Model for patient consent and collection of fit-for-purpose biospecimens.

Figure 4. Operational workflows depict the integration of the Biorepository Program within Infusion, Clinics,
Surgery, Pathology and Laboratory Departments. All pertinent staff are trained on the processes set forth using
these workflows, that are considered the operational blueprints of the Program.

Collaborative Strategy
Staff Meeting Presentations
• The Biorepository Program common goals and updates are presented at the various departmental staff
meetings to disseminate current research involvement, share quality measures and growth data, identify
challenges and seek ways to improve processes.
Departmental Rounding
• As ambassadors of the Biorepository Program, the BRF staff rounds on all pivotal departments on a weekly
basis. Our presence within these Departments remains consistent so that the expectation is set; the
Biorepository Program delivers excellence to the research community and contributes to BHSF standards.
Leadership Meetings
• Monthly/Quarterly meetings with the Departments’ leadership teams provide a forum to discuss progress,
implement changes, and facilitate program expansion.
Bi-weekly MCI Data Mart Meetings
• Continued work on complex data accessibility and building data analysis capacity.
• Implementation of strategies to build alerts within the EMR for multi-pronged, longitudinal research requests.
The Biospecimen and Data Release Committee (BDRC)
• Monthly meetings to review all requests for use of biospecimens and/or data for research purposes or to
initiate a prospective biospecimen collection.
• Members represent key institutional stakeholders and Departments.
The BRF Dashboard
• Dynamic and real-time dashboard published to display the Biorepository Program productivity and availability
of biospecimens for research

Figure 7. The 2019 BRF interactive dashboard provides real-time productivity data related to patient enrollment
and biospecimen collection by disease site and illustrates how the various Departments’ involvement directly
impact productivity.

Conclusions
• The Biorepository Program has been capitalizes and integrates six pivotal Departments and uses a
collaborative model to enroll patients and collect biospecimens for research purposes.
• An increase in productivity was observed in 2019,compared to the first year of operations. Patient enrollment
increased by 52% and biospecimens banked increased by 46%.
• A culture shift within the collaborative Departments towards genuine support have resulted in a wealth of
resources the Biorepository program can provide to expedite discoveries and its translation to more effective
diagnostics and therapeutics.
• There is an exponential increase in requests of high quality and clinically annotated biospecimens from
academic, industry and internal investigators.

Figure 2. Collaborative Operational Model for patient
consent began in January 2018 and has gradually
expanded, allowing flexibility to target patients for
enrollment.

• The Biorepository Program is well equipped to share these biospecimens in an expedited and compliant
manner.

A Shift in the Research Paradigm
• To fulfill the research requirements of the many intricate requests the BRF receives at a rather expedited
pace, particularly from our affiliated university members, the collaborative infrastructure must expand to other
Baptist Health South Florida locations. The processes shown here must be tailored to these locations and to
the new patient cohorts targeted.

Figure 3. The MCI Data Mart provides associated
clinical data obtained via EMR to allow for multidisciplinary research in a variety of research
initiatives.

• The expansion of consenting capabilities to health care professionals as well as the implementation of an econsenting platform will increase enrollment efficiency and collection of key biospecimens on real-time.
Figure 5. The Requestor Workflow details the process by which all requests to the BRF are handled. Biospecimen
and Data Release Committee approval is the gateway for all research endeavors.

• The establishment of an IT platform for locating and sharing remnant biospecimens collecting for clinical
purposes will increase the support provided by Baptist Health South Florida infrastructure to the generation of
new knowledge and more effective diagnostics and therapeutics strategies.

